Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB4211
    • CB5138 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 26, 2018 9:00am EDT

CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

Mar 19, 2018 4:35pm EDT

CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018

Dec 13, 2017 12:53pm EST

CohBar Announces Approval for Listing on the NASDAQ Capital Market

Dec 07, 2017 9:00am EST

CohBar Announces the Appointment of Dr. John Amatruda to its Board

Nov 13, 2017 4:03pm EST

CohBar, Inc. Announces Third Quarter 2017 Financial Results

Oct 26, 2017 9:00am EDT

CohBar, Inc. to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

Oct 23, 2017 9:00am EDT

CohBar Presents Preclinical Data on CB4209/CB4211 Program for NASH at the AASLD Liver MeetingĀ® 2017

Oct 04, 2017 9:00am EDT

CohBar, Inc. Announces Scientific Presentation of CB4209/CB4211 Program for NASH at The AASLD Liver MeetingĀ® 2017

Sep 08, 2017 9:00am EDT

CohBar to Present at the Rodman & Renshaw 19th Annual Global Investment Conference in New York on September 12, 2017

Aug 14, 2017 4:05pm EDT

CohBar, Inc. Announces Second Quarter 2017 Financial Results

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Next Pagearrow_forward
  • Email Alerts
  • Tear Sheet
  • Contacts
©2023 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use